中国·太阳成集团tyc122cc(股份)有限公司-搜狗百科
Home
About Us
Company Profile
Milestones
CSR
Contact Us
Product Solutions
Structural Heart Solutions
Peripheral Vascular Solutions
Product Manuals
Research & Development
News
Company News
Investor Relations
Stock Information
Announcements & Financial Reports
Corporate Governance
IR Contacts
Join Us
中文
Investor Relations
Announcements
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2022
2022
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Search
View / Download
2022 / 04 / 20
PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY
View / Download
2022 / 04 / 06
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2022
View / Download
2022 / 03 / 30
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021
View / Download
2022 / 03 / 14
VOLUNTARY ANNOUNCEMENT - The first enrollment for confirmatory clinical trials of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System had been completed in China
View / Download
2022 / 03 / 11
NOTICE OF BOARD MEETING
View / Download
2022 / 03 / 04
DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF PRINCIPAL-PROTECTED STRUCTURED DEPOSIT
View / Download
2022 / 03 / 04
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2022
View / Download
2022 / 03 / 03
ADOPTION OF THE 2022 SHARE AWARD SCHEME
View / Download
2022 / 02 / 08
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2022
View / Download
2022 / 01 / 06
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2021
·
1
2
3
